Literature DB >> 12161844

Motor vehicle crashes and violations among drivers with multiple sclerosis.

Maria T Schultheis1, Edward Garay, Scott R Millis, John Deluca.   

Abstract

OBJECTIVE: To investigate differences in the incidence of motor vehicle crashes (MVCs) and violations among drivers with multiple sclerosis (MS) when cognitive impairment is present.
DESIGN: Archival evaluation of Department of Motor Vehicles (DMV) records.
SETTING: Medical rehabilitation research organization. PARTICIPANTS: Community-dwelling drivers, 27 subjects with documented MS (14 MS without cognitive impairment [MS-], 13 MS with cognitive impairment [MS+]) and 17 healthy control subjects, matched on age, sex, and driving experience.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Incidence of MVCs and motor vehicle violations as documented by DMV reports for the past 5 years.
RESULTS: MS+ subjects showed a higher incidence of MVCs when compared with control and MS- subjects. No significant difference in the incidence of motor vehicle violations was observed between groups.
CONCLUSIONS: The presence of cognitive impairment in drivers with MS can result in an increased risk of MVC involvement. Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Entities:  

Mesh:

Year:  2002        PMID: 12161844     DOI: 10.1053/apmr.2002.34279

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  14 in total

1.  A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Heather Becker; Frank Perez; Janet Morison; Vicki Kullberg; Ana Todd
Journal:  Clin Rehabil       Date:  2012-02-02       Impact factor: 3.477

2.  Prediction of driving ability in people with relapsing-remitting multiple sclerosis using the stroke driver screening assessment.

Authors:  Abiodun Emmanuel Akinwuntan; Christina O'Connor; Erin McGonegal; Kristen Turchi; Suzanne Smith; Mitzi Williams; Jerry Wachtel
Journal:  Int J MS Care       Date:  2012

3.  Driving after traumatic brain injury: evaluation and rehabilitation interventions.

Authors:  Maria T Schultheis; Elizabeth Whipple
Journal:  Curr Phys Med Rehabil Rep       Date:  2014-09

4.  The contribution of cognition and spasticity to driving performance in multiple sclerosis.

Authors:  Thomas D Marcotte; Theodore J Rosenthal; Erica Roberts; Sara Lampinen; J Cobb Scott; R Wade Allen; Jody Corey-Bloom
Journal:  Arch Phys Med Rehabil       Date:  2008-09       Impact factor: 3.966

Review 5.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 6.  Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

Authors:  Christopher Christodoulou; William S MacAllister; Nancy A McLinskey; Lauren B Krupp
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 7.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

8.  Object decision and multiple sclerosis: a preliminary study.

Authors:  N Caputi; A Matrella; Rocco Totaro; C Raparelli; S Pontecorvo; D Di Giacomo; D Passafiume
Journal:  Funct Neurol       Date:  2017 Apr/Jun

Review 9.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

10.  Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

Authors:  Ralph H B Benedict; Maria Pia Amato; Jan Boringa; Bruno Brochet; Fred Foley; Stan Fredrikson; Paivi Hamalainen; Hans Hartung; Lauren Krupp; Iris Penner; Anthony T Reder; Dawn Langdon
Journal:  BMC Neurol       Date:  2012-07-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.